|
1
|
Dworkin RH, Turk DC, Katz NP, Rowbotham
MC, Peirce-Sandner S, Cerny I, Clingman CS, Eloff BC, Farrar JT,
Kamp C, et al: Evidence-based clinical trial design for chronic
pain pharmacotherapy: A blueprint for ACTION. Pain. 152 3
Suppl:S107–S115. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ivanova JI, Birnbaum HG, Yushkina Y, Sorg
RA, Reed J and Merchant S: The prevalence and economic impact of
prescription opioid-related side effects among patients with
chronic noncancer pain. J Opioid Manag. 9:239–254. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jurga AM, Rojewska E, Piotrowska A, Makuch
W, Pilat D, Przewlocka B and Mika J: Blockade of Toll-like
receptors (TLR2, TLR4) attenuates pain and potentiates
buprenorphine analgesia in a rat neuropathic pain model. Neural
Plast. 2016:52387302016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ma YQ, Chen YR, Leng YF and Wu ZW:
Tanshinone IIA downregulates HMGB1 and TLR4 expression in a spinal
nerve ligation model of neuropathic pain. Evid Based Complement
Alternat Med. 2014:6395632014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hutchinson MR, Zhang Y, Brown K, Coats BD,
Shridhar M, Sholar PW, Patel SJ, Crysdale NY, Harrison JA, Maier
SF, et al: Non-stereoselective reversal of neuropathic pain by
naloxone and naltrexone: Involvement of Toll-like receptor 4
(TLR4). Eur J Neurosci. 28:20–29. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bettoni I, Comelli F, Rossini C, Granucci
F, Giagnoni G, Peri F and Costa B: Glial TLR4 receptor as new
target to treat neuropathic pain: Efficacy of a new receptor
antagonist in a model of peripheral nerve injury in mice. Glia.
56:1312–1319. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kaur IP and Sharma G: siRNA: A new
approach to target neuropathic pain. BioDrugs. 26:401–412. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu F, Liu Y, Lv X, Miao X, Sun Y and Yu W:
Small interference RNA targeting TLR4 gene effectively attenuates
pulmonary inflammation in a rat model. BioMed Res Int.
2012:4064352012.
|
|
9
|
Wu FX, Bian JJ, Miao XR, Huang SD, Xu XW,
Gong DJ, Sun YM, Lu ZJ and Yu WF: Intrathecal siRNA against
Toll-like receptor 4 reduces nociception in a rat model of
neuropathic pain. Int J Med Sci. 7:251–259. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu F, Pan R, Chen J, Sugita M, Chen C, Tao
Y, Yu W and Sun Y: Lentivirus mediated siRNA against GluN2B Subunit
of NMDA receptor reduces nociception in a rat model of neuropathic
pain. Biomed Res Int. 2014:8716372014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pan R, Di H, Zhang J, Huang Z, Sun Y, Yu W
and Wu F: Inducible lentivirus-mediated siRNA against TLR4 reduces
nociception in a rat model of bone cancer pain. Mediators Inflamm.
2015:5238962015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bennett GJ and Xie YK: A peripheral
mononeuropathy in rat that produces disorders of pain sensation
like those seen in man. Pain. 33:87–107. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ge Y, Wu F, Sun X, Xiang Z, Yang L, Huang
S, Lu Z, Sun Y and Yu WF: Intrathecal infusion of hydrogen-rich
normal saline attenuates neuropathic pain via inhibition of
activation of spinal astrocytes and microglia in rats. PLoS One.
9:e974362014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Milligan ED, Hinde JL, Mehmert KK, Maier
SF and Watkins LR: A method for increasing the viability of the
external portion of lumbar catheters placed in the spinal
subarachnoid space of rats. J Neurosci Methods. 90:81–86. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hargreaves K, Dubner R, Brown F, Flores C
and Joris J: A new and sensitive method for measuring thermal
nociception in cutaneous hyperalgesia. Pain. 32:77–88. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu F, Miao X, Chen J, Sun Y, Liu Z, Tao Y
and Yu W: Down-regulation of GAP-43 by inhibition of caspases-3 in
a rat model of neuropathic pain. Int J Clin Exp Pathol. 5:948–955.
2012.PubMed/NCBI
|
|
17
|
Lan LS, Ping YJ, Na WL, Miao J, Cheng QQ,
Ni MZ, Lei L, Fang LC, Guang RC, Jin Z and Wei L: Down-regulation
of Toll-like receptor 4 gene expression by short interfering RNA
attenuates bone cancer pain in a rat model. Mol Pain. 6:22010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (-Delta Delta C (T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
An G, Lin TN, Liu JS, Xue JJ, He YY and
Hsu CY: Expression of c-fos and c-jun family genes after focal
cerebral ischemia. Ann Neurol. 33:457–464. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu F, Miao X, Chen J, Liu Z, Tao Y, Yu W
and Sun Y: Inhibition of GAP-43 by propentofylline in a rat model
of neuropathic pain. Int J Clin Exp Pathol. 6:1516–1522.
2013.PubMed/NCBI
|
|
21
|
Liu T, Han Q, Chen G, Huang Y, Zhao LX,
Berta T, Gao YJ and bJi RR: Toll-like receptor 4 contributes to
chronic itch, alloknesis, and spinal astrocyte activation in male
mice. Pain. 157:806–817. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vijayan V, Khandelwal M, Manglani K, Gupta
S and Surolia A: Methionine down-regulates TLR4/MyD88/NF-κB
signalling in osteoclast precursors to reduce bone loss during
osteoporosis. Br J Pharmacol. 171:107–121. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wieland CW, Florquin S, Maris NA, Hoebe K,
Beutler B, Takeda K, Akira S and van der Poll T: The
MyD88-dependent, but not the MyD88-independent, pathway of TLR4
signaling is important in clearing nontypeable haemophilus
influenzae from the mouse lung. J Immunol. 175:6042–6049. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lin J, Wang H, Li J, Wang Q, Zhang S, Feng
N, Fan R and Pei J: κ-Opioid receptor stimulation modulates
TLR4/NF-κB signaling in the rat heart subjected to
ischemia-reperfusion. Cytokine. 61:842–848. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Song Y, Shi Y, Ao LH, Harken AH and Meng
XZ: TLR4 mediates LPS-induced HO-1 expression in mouse liver: Role
of TNF-α and IL-1β. World J Gastroenterol. 9:1799–1803. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ichim TE, Li M, Qian H, Popov IA, Rycerz
K, Zheng X, White D, Zhong R and Min WP: RNA Interference: A potent
tool for gene-specific therapeutics. Am J Transplant. 4:1227–1236.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Elbashir SM, Lendeckel W and Tuschl T: RNA
interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev.
15:188–200. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lambeth LS and Smith CA: Short hairpin
RNA-mediated gene silencing. Methods Mol Biol. 942:205–232. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Welman A, Barraclough J and Dive C:
Tetracycline regulated systems in functional oncogenomics. Transl
Oncogenomics. 2:17–33. 2007.PubMed/NCBI
|
|
30
|
Pluta K, Luce MJ, Bao L, Agha-Mohammadi S
and Reiser J: Tight control of transgene expression by lentivirus
vectors containing second-generation tetracycline-responsive
promoters. J Gene Med. 7:803–817. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Moriyama H, Moriyama M, Sawaragi K, Okura
H, Ichinose A, Matsuyama A and Hayakawa T: Tightly regulated and
homogeneous transgene expression in human adipose-derived
mesenchymal stem cells by lentivirus with tet-off system. PLoS One.
8:e662742013. View Article : Google Scholar : PubMed/NCBI
|
